Protocol for the MpoxCARE Study: A Comprehensive Evaluation of Immunization Strategies During Emergency Outbreaks of Mpox - Top-Institutions - MDSpire

Protocol for the MpoxCARE Study: A Comprehensive Evaluation of Immunization Strategies During Emergency Outbreaks of Mpox

  • By

  • Karishma Gokani

  • Herve Semukunzi

  • Gilbert Rukundo

  • Jenny Clarke

  • Sian E. Faustini

  • Jean Pierre Musabyimana

  • Siobhan Roche

  • Scott Jones

  • Ashley David Otter

  • Alex Richter

  • Claude Muvunyi

  • Jennifer Heaney

  • Christopher Aird Green

  • February 13, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Centers for Disease Control and Prevention (CDC)
    Centers for Disease Control and Prevention (CDC)

    Atlanta, GA

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Vaccine Research

  • #2

    National Institute of Allergy and Infectious Diseases (NIAID), NIH
    National Institute of Allergy and Infectious Diseases (NIAID), NIH

    Bethesda, MD

    Key Differentiators

    • Immunology
    • Vaccine Development
    • Infectious Diseases

  • #3

    Institut Pasteur
    Institut Pasteur

    Paris, Île-de-France

    Key Differentiators

    • Virology
    • Infectious Diseases
    • Vaccine Research

  • #4

    African Centre for Disease Control and Prevention (Africa CDC)
    African Centre for Disease Control and Prevention (Africa CDC)

    Addis Ababa, Ethiopia

    Key Differentiators

    • Public Health
    • Infectious Disease Control
    • Epidemiology

  • #5

    University of Oxford, Nuffield Department of Medicine
    University of Oxford, Nuffield Department of Medicine

    Oxford, Oxfordshire

    Key Differentiators

    • Infectious Diseases
    • Vaccine Development
    • Clinical Trials

Original Source(s)

Protocol for the MpoxCARE Study: A Comprehensive Evaluation of Immunization Strategies During Emergency Outbreaks of Mpox

  • by Karishma Gokani, Herve Semukunzi, Gilbert Rukundo, Jenny Clarke, Sian E. Faustini, Jean Pierre Musabyimana, Siobhan Roche, Scott Jones, Ashley David Otter, Alex Richter, Claude Muvunyi, Jennifer Heaney, Christopher Aird Green

  • February 13, 2026

Related Content

Assessing PEPFAR’s Health Spillover Effects Beyond HIV: An Update

Side Effects: Nobody Trained for This

Chemsex at the pharmacy counter. Gut bacteria tracking helmet impacts. PMD predicting psychiatric illness bidirectionally. This week's research keeps landing in the same uncomfortable place: medicine is improvising.

Effectiveness of Nirmatrelvir/Ritonavir for Outpatients in the Era of Omicron, Vaccination, and Previous Infection: A Meta-analysis